Screening Coronary CT Angiography: No Time Soon

Journal of the American College of Radiology

Volumn 4, Issue 5, 2007, Pages 295-299

  Black, William C ^a   Czum, Julianna M ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL TRIAL; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DRUG WITHDRAWAL; EXERCISE; HUMAN; MORBIDITY; MYALGIA; RISK ASSESSMENT; SCREENING; SCREENING TEST; SIDE EFFECT; SMOKING CESSATION; WEIGHT REDUCTION;

EID: 34247395814     PISSN: 15461440     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacr.2007.03.001     Document Type: Article

References (34)

1. Dowe D.A. The case in favor of screening for coronary artery disease with coronary CT angiography. J Am Coll Radiol 4 (2007) 289-294
2. Obuchowski N.A., Graham R.J., Baker M.E., and Powell K.A. Ten criteria for effective screening: their application to multislice CT screening for pulmonary and colorectal cancers. AJR Am J Roentgenol 176 (2001) 1357-1362
3. Lloyd-Jones D.M., Larson M.G., Beiser A., and Levy D. Lifetime risk of developing coronary heart disease. Lancet 353 (1999) 89-92
4. Minino A.M., Heron M.P., and Smith B.L. Deaths: preliminary data for 2004. Natl Vital Stat Rep 54 (2006) 1-49
5. McNamara J.J., Molot M.A., Stremple J.F., and Cutting R.T. Coronary artery disease in combat casualties in Vietnam. JAMA 216 (1971) 1185-1187
6. Tuzcu E.M., Kapadia S.R., Tutar E., Ziada K.M., Hobbs R.E., McCarthy P.M., Young J.B., and Nissen S.E. High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: evidence from intravascular ultrasound. Circulation 103 (2001) 2705-2710
7. Black W.C., and Welch H.G. Screening for disease. AJR Am J Roentgenol 168 (1997) 3-11
8. Budoff M.J., Achenbach S., Blumenthal R.S., et al. Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology. Circulation 114 (2006) 1761-1791
9. Leber A.W., Becker A., Knez A., et al. Accuracy of 64-slice computed tomography to classify and quantify plaque volumes in the proximal coronary system: a comparative study using intravascular ultrasound. J Am Coll Cardiol 47 (2006) 672-677
10. Nikolaou K., Knez A., Rist C., et al. Accuracy of 64-MDCT in the diagnosis of ischemic heart disease. AJR Am J Roentgenol 187 (2006) 111-117
11. Burke A.P., Farb A., Malcom G.T., Liang Y., Smialek J.E., and Virmani R. Plaque rupture and sudden death related to exertion in men with coronary artery disease. JAMA 281 (1999) 921-926
12. Brenner D.J., and Elliston C.D. Estimated radiation risks potentially associated with full-body CT screening. Radiology 232 (2004) 735-738
13. Lau G.T., Ridley L.J., Schieb M.C., et al. Coronary artery stenoses: detection with calcium scoring, CT angiography, and both methods combined. Radiology 235 (2005) 415-422
14. Katayama H., Yamaguchi K., Kozuka T., Takashima T., Seez P., and Matsuura K. Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology 175 (1990) 621-628
15. Lasser E.C., Lyon S.G., and Berry C.C. Reports on contrast media reactions: analysis of data from reports to the U.S. Food and Drug Administration. Radiology 203 (1997) 605-610
16. Lawler L.P., Pannu H.K., and Fishman E.K. MDCT evaluation of the coronary arteries, 2004: how we do it-data acquisition, postprocessing, display, and interpretation. AJR Am J Roentgenol 184 (2005) 1402-1412
17. Ko D.T., Hebert P.R., Coffey C.S., et al. Adverse effects of beta-blocker therapy for patients with heart failure: a quantitative overview of randomized trials. Arch Intern Med 164 (2004) 1389-1394
18. Budoff M.J., Fischer H., and Gopal A. Incidental findings with cardiac CT evaluation: should we read beyond the heart?. Catheter Cardiovasc Interv 68 (2006) 965-973
19. US Census Bureau. Statistical abstract of the United States. Available at: http://www.census.gov/prod/2006pubs/07statab/pop.pdf. Accessed March 2, 2007.
20. Dowe D.A. How to win the coronary CTA turf war. AJR Am J Roentgenol 187 (2006) 849-851
21. Hooper L., Summerbell C.D., Higgins J.P., et al. Dietary fat intake and prevention of cardiovascular disease: systematic review. BMJ 322 (2001) 757-763
22. Hennekens C.H., Hollar D., Eidelman R.S., and Agatston A.S. Update for primary healthcare providers: recent statin trials and revised National Cholesterol Education Program III guidelines. MedGenMed 8 (2006) 54
23. Psaty B.M., Lumley T., Furberg C.D., et al. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA 289 (2003) 2534-2544
24. McGill Jr. H.C., and McMahan C.A. Starting earlier to prevent heart disease. JAMA 290 (2003) 2320-2322
25. Pietinen P., Vartiainen E., Seppanen R., Aro A., and Puska P. Changes in diet in Finland from 1972 to 1992: impact on coronary heart disease risk. Prev Med 25 (1996) 243-250
26. Serruys P.W., Kutryk M.J., and Ong A.T. Coronary-artery stents. N Engl J Med 354 (2006) 483-495
27. Laatikainen T., Critchley J., Vartiainen E., Salomaa V., Ketonen M., and Capewell S. Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997. Am J Epidemiol 162 (2005) 764-773
28. Gemmell I., Heller R.F., Payne K., Edwards R., Roland M., and Durrington P. Potential population impact of the UK government strategy for reducing the burden of coronary heart disease in England: comparing primary and secondary prevention strategies. Qual Saf Health Care 15 (2006) 339-343
29. McKenney J.M., Davidson M.H., Jacobson T.A., Guyton J.R., and National Lipid Association Statin Safety Assessment Task Force. Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force. Am J Cardiol 97 suppl (2006) 89C-94C
30. Bild D.E., Bluemke D.A., Burke G.L., et al. Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol 156 (2002) 871-881
31. O'Malley P.G., Taylor A.J., Gibbons R.V., et al. Rationale and design of the Prospective Army Coronary Calcium (PACC) study: utility of electron beam computed tomography as a screening test for coronary artery disease and as an intervention for risk factor modification among young, asymptomatic, active-duty United States Army personnel. Am Heart J 137 (1999) 932-941
32. Khot U.N., Khot M.B., Bajzer C.T., et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA 290 (2003) 898-904
33. Steinwald AB. Health care spending: public payers face burden of entitlement program growth, while all payer face rising prices and increasing use of services. Available at: http://www.gao.gov/new.items/d07497t.pdf. Accessed March 1, 2007.
34. Naska A., Oikonomou E., Trichopoulou A., Psaltopoulou T., and Trichopoulos D. Siesta in healthy adults and coronary mortality in the general population. Arch Intern Med 167 (2007) 296-301